Implications of Failure to Routinely Diagnose Resistance to Second-Line Drugs in Patients With Rifampicin-Resistant Tuberculosis on Xpert MTB/RIF: A Multisite Observational Study.

about

Stool Culture for Diagnosis of Pulmonary Tuberculosis in Children.

P2860

Q40048035-0DBB5349-EEC7-40B5-8000-8936FFC5D41A

P2860

Implications of Failure to Routinely Diagnose Resistance to Second-Line Drugs in Patients With Rifampicin-Resistant Tuberculosis on Xpert MTB/RIF: A Multisite Observational Study.

Item

http://www.wikidata.org/entity/Q40332311

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Implications of Failure to Rou ...... Multisite Observational Study.

@en

type

Item

label

Implications of Failure to Rou ...... Multisite Observational Study.

@en

prefLabel

Implications of Failure to Rou ...... Multisite Observational Study.

@en

P1476

Implications of Failure to Rou ...... Multisite Observational Study.

@en

P2093

Annelies Van Rie

http://www.w3.org/2001/XMLSchema#string

Elizabeth J Ragan

http://www.w3.org/2001/XMLSchema#string

John Simpson

http://www.w3.org/2001/XMLSchema#string

Lesley Scott

http://www.w3.org/2001/XMLSchema#string

Marinus Barnard

http://www.w3.org/2001/XMLSchema#string

Ofer Shapira

http://www.w3.org/2001/XMLSchema#string

Paul D van Helden

http://www.w3.org/2001/XMLSchema#string

Tania Dolby

http://www.w3.org/2001/XMLSchema#string

Wendy Stevens

http://www.w3.org/2001/XMLSchema#string

P2860

New Antituberculosis Drugs: From Clinical Trial to Programmatic Use

A Global Perspective on Pyrazinamide Resistance: Systematic Review and Meta-Analysis

Prevalence of and risk factors for resistance to second-line drugs in people with multidrug-resistant tuberculosis in eight countries: a prospective cohort study

Impact of Decentralized Care and the Xpert MTB/RIF Test on Rifampicin-Resistant Tuberculosis Treatment Initiation in Khayelitsha, South Africa

Screening for HIV-associated tuberculosis and rifampicin resistance before antiretroviral therapy using the Xpert MTB/RIF assay: a prospective study

Multidrug resistant pulmonary tuberculosis treatment regimens and patient outcomes: an individual patient data meta-analysis of 9,153 patients

Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study

Multicenter laboratory validation of susceptibility testing of Mycobacterium tuberculosis against classical second-line and newer antimicrobial drugs by using the radiometric BACTEC 460 technique and the proportion method with solid media.

Effects of introducing Xpert MTB/RIF test on multi-drug resistant tuberculosis diagnosis in KwaZulu-Natal South Africa.

Population structure of multi- and extensively drug-resistant Mycobacterium tuberculosis strains in South Africa.

P304

1502-1508

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/CID/CIX128

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28199520

http://www.w3.org/2001/XMLSchema#string

P932

5434334

http://www.w3.org/2001/XMLSchema#string

Implications of Failure to Routinely Diagnose Resistance to Second-Line Drugs in Patients With Rifampicin-Resistant Tuberculosis on Xpert MTB/RIF: A Multisite Observational Study.

about

P2860

P2860

Implications of Failure to Routinely Diagnose Resistance to Second-Line Drugs in Patients With Rifampicin-Resistant Tuberculosis on Xpert MTB/RIF: A Multisite Observational Study.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932